logo
logo
AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting
Start with:
7-day trial • $39/mo or $29/mo annual
AI + proprietary hiring database
Executive contact details included
INDUSTRY FIRST

Allan Oberman, President & CEO of Apotex To Present At Jefferies Healthcare Conference

Jun 04, 2024about 1 year ago

Position

President

Company

Apotex

Allan Oberman

Description

Allan Oberman, President & CEO of Apotex, will be presenting at the Jefferies Healthcare Conference on Wednesday, June 5th, 2024 at 9:00 am EST in New York, NY.

Company Information

Company

Apotex

About

www.apotex.com.

Company News

(10 articles)
Wed, 02 Jul 2025 07:00:00 GMT

Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats - PR Newswire

Fri, 09 May 2025 07:00:00 GMT

Apotex introduces IVRA™ (Melphalan) hydrochloride injection: First ready to dilute liquid formulation of Melphalan injection approved via 505(b)(2) NDA in the United States - PR Newswire

Wed, 04 Sep 2024 07:00:00 GMT

Apotex Corp. is the first generic manufacturer to launch dasatinib tablets in the United States - Yahoo Finance

Mon, 14 Oct 2024 07:00:00 GMT

Novo Nordisk Sues Apotex to Block Generic Version of Rybelsus - Bloomberg Law News

Tue, 06 May 2025 07:00:00 GMT

Apotex announces expansion of licensing agreement with Formosa Pharmaceuticals to Mexico for commercialization of clobetasol propionate ophthalmic suspension for the treatment of inflammation and pain following ocular surgery - PR Newswire

Thu, 15 Feb 2024 08:00:00 GMT

Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products - Business Wire

Wed, 10 Jul 2019 07:00:00 GMT

The hits keep coming: Apotex loses 31 drug approvals after FDA cites plants for 'inadequate' controls - Fierce Pharma

Wed, 28 Sep 2022 07:00:00 GMT

Drug company Apotex formerly owned by Barry Sherman agrees to takeover - CBC

Tue, 06 May 2025 07:00:00 GMT

Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Post-Ocular Surgery Inflammation and Pain for Mexico - PR Newswire

Mon, 24 Feb 2025 08:00:00 GMT

Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal - PR Newswire

FundzWatch™ Score

82
Medium Activity

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months